Compositions comprising bioactive peptides prepared without formation of native disulfide bonds
AssigneeBiotherapeutics, Inc.
InventorsDavid D. Mundschenk, Leonard A. Smith
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiotherapeutics, Inc.
InventorsDavid D. Mundschenk, Leonard A. Smith
Estimating the term…
A method of preparing a bioactive polypeptide in a stable, inactivated form, the method comprising the step of treating the polypeptide with ozonated water in order to oxidize and/or stabilize the cysteine residues, and in turn, prevent the formation of disulfide bridges necessary for bioactivity. The method can involve the use of ozonated water to both oxidize the disulfide bridges in a bioactive polypeptide, and to then stabilize the resultant cysteine residues. Optionally, and preferably, the method can involve the use of ozonated water to stabilize the cysteine residues, and thereby prevent the formation of disulfide bridges, in a polypeptide produced by recombinant means in a manner that allows the polypeptide to be recovered with the disulfide bridges unformed.
A composition comprising a polypeptide rendered atoxic by the prevention of formation of disulfide bonds in its tertiary structure prepared according to a method comprising the steps of:
Dependencies are inferred from the claim text.